A firm behind revolutionary blindness treatment has been praised for its affects in diabetic patients during Covid-19.
Sedgefield firm’s light therapy masks help treat diabetic retinopathy during Covid-19
NHS and Government
NHS and Government
Sleep mask could aid diabetic retinopathy screening
The study showed that 94% of all patients who correctly used the mask showed significant stabilisation and sometimes even improvement of the central diabetic maculopathy and vision with some patients seeing a reverse of their condition.
Novel treatment developed at NETPark helping diabetic patients during lockdown
A Consultant Ophthalmic Surgeon at Ashford and St Peter’s NHS Hospital near London has found that treating the eyes of diabetic patients with the Noctura 400 eye mask might stabilise or even improve central diabetic retinopathy changes.
Richard Kirk at 10 Downing Street
Richard Kirk, CEO outside 10 Downing Street after attending the launch of the second Life Sciences Sector Deal.
Academic Health Science Network report
The national AHSN Network of fifteen AHSNs has published its first report and PolyPhotonix feature on page 11.
A bold new idea and real vision
North East & North Cumbria AHSN celebrate PolyPhotonix success
The North East & North Cumbria Academic Health Science Network have published an article celebrating Richard Kirk’s win at the BQ Emerging Entrepreneur Awards.
West of England AHSN promote Noctura 400
The West of England AHSN have posted a video about Noctura 400 on their Health Innovation channel to encourage collaborations with healthcare professionals.
Revolutionising diabetic retinopathy prevention and treatment
Kent Surrey Sussex AHSN are working with PolyPhotonix, from early engagement with clinicians to understanding the NHS marketplace.
LED ‘sleep mask’ tackles causes of sight-loss
British artist turned entrepreneur develops new technology to treat common causes of blindness, with support from Innovate UK.